Johanna Joyce, PhD, then took the rostrum and spoke eloquently on the tumor microenvironment, underscoring the immense ...

GEN's Julianna LeMieux and IPM's Damian Doherty provide highlights of the first day of the AACR 2025 meeting in Chicago.

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

Velsera and Complete Genomics are expanding their ability to serve clinical labs with an end-to-end solution from sample to ...

A fundamental discovery in how the immune system organizes itself to respond better to external threats,” researchers find in study.

University of Pittsburgh scientists working with UPMC infection preventionists have developed an infectious diseases ...

Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...

AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...

Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with guests.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.